106120-04-1Relevant articles and documents
ADMET Polymers Containing Precisely Spaced Pendant Boronic Acids and Esters
Simocko, Chester,Young, Thomas C.,Wagener, Kenneth B.
, p. 5470 - 5473 (2015)
Precise aryl boronic ester- and acid-containing polymers have been synthesized via acyclic diene metathesis. High-molecular weight phenyl boronic acid polymers were synthesized. Cross-linked phenyl boronic acid polymers were also synthesized and demonstrate a unique crystallization behavior not usually seen in cross-linked polymers. (Graph Presented).
Metal-free OLED triplet emitters by side-stepping Kasha's rule
Chaudhuri, Debangshu,Sigmund, Eva,Meyer, Annemarie,Roeck, Lisa,Klemm, Philippe,Lautenschlager, Sebastian,Schmid, Agnes,Yost, Shane R.,Vanvoorhis, Troy,Bange, Sebastian,Hoeger, Sigurd,Lupton, John M.
, p. 13449 - 13452 (2013)
Keeping it light: Most organic fluorophores do not show useful emission from the triplet excited state. A new class of materials is presented for organic light-emitting diodes that exhibit phosphorescence under electrical excitation, even at room temperat
Acylative desymmetrization of cyclic meso-1,3-diols by chiral DMAP derivatives
Mandai, Hiroki,Hironaka, Tsubasa,Mitsudo, Koichi,Suga, Seiji
supporting information, p. 471 - 474 (2021/03/15)
An efficient enantioselective acylative desymmetrization of cyclic meso-1,3-diols was developed by using a chiral DMAP derivative 1e having a 1,1¤-binaphthyl unit. The reactions required only 0.5mol% of the catalyst and showed good to excellent enantioselectivity. With this transformation, 5a, a key building block for the synthesis of natural products, was easily obtained in almost enantiomerically pure form after a single recrystallization. Control experiments revealed that tert-alcohol units on the catalyst were responsible for both the catalytic activity and enantioselectivity.
CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS OF USE
-
Page/Page column 442; 461-462, (2020/05/28)
The subject matter described herein is directed to antibody-CIDE conjugates (Ab-CIDEs), to pharmaceutical compositions containing them, and to their use in treating diseases and conditions where targeted protein degradation is beneficial.